Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-848-3 | CAS number: 75-20-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007-03-22 to 2007-04-26
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- GLP guideline study performed with the relevant decomposition product Ca(OH)2; Minor deviations without an effect on the study results: - A rationale for choosing the limit dose was not given.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Version / remarks:
- adopted 2006-03-23
- Deviations:
- yes
- Remarks:
- see "rationale for reliability"
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed November 2005
- Test type:
- up-and-down procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Calcium dihydroxide
- EC Number:
- 215-137-3
- EC Name:
- Calcium dihydroxide
- Cas Number:
- 1305-62-0
- Molecular formula:
- CaH2O2
- IUPAC Name:
- calcium dihydroxide
- Reference substance name:
- Calcium hydroxide
- IUPAC Name:
- Calcium hydroxide
- Details on test material:
- - Name of test material (as cited in study report): Precal 50S (Calcium dihydroxide (hydrated lime)
- Physical state: White powder
- Analytical purity: 98.2 %
- Batch No.: 7025
- Expiration date of the batch: January 2009
- Stability of test item: Stable under storage conditions
- Storage condition of test material: At room temperature (range of 22 +/- 5°C), moisture protected
No further information on the test material was stated.
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd, Laboratory Animal Services, CH-4414 Füllinsdorf/Switzerland
- Age at study initiation: 11 weeks
- Weight at study initiation: 185.1 to 206.5 g
- Fasting period before study: Approximately 16 to 19 hours; Food was provided again approximately 3 hours after dosing
- Housing: Individually in Makrolon type-3 cages with standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz) during treatment and observations
- Diet (ad libitum): Pelleted standard Provimi Kliba 3433 rat/mouse maintenance diet, batch no. 80/06 or 89/06 (Provimi Kliba AG, CH-4303 Kaiseraugst/Switzerland)
- Water (ad libitum): Community tap water from Füllinsdorf
- Acclimation period: Seven days under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature: 22 +/- 3°C
- Humidity: 30-70 %
- Air changes: 10-15 air changes per hour
- Photoperiod (hrs dark / hrs light): 12/12
No further information on the test animals was stated.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on oral exposure:
- VEHICLE: Polyethylene glycol 300 (PEG 300)
- Description: Colourless viscous liquid
- Source: FLUKA Chemie GmbH, CH-9471 Buchs
- Stability of vehicle: Stable under storage conditions
- Expiration date: October 2007
- Storage conditions: At room temperature (range of 20 +/- 5°C), light protected
- Justification for choice of vehicle: The vehicle was chosen after a non-GLP solubility trial which was performed before the study initiation date. Polyethylene glycol 300 was the most suitable vehicle selected for the test item.
- Lot no.: 1300225
- Concentration in vehicle: 0.2 g/mL
MAXIMUM DOSE VOLUME APPLIED: The application volume was 10 mL/kg body weight.
DOSAGE PREPARATION:
The dose formulations were made shortly (i.e. less than 30 minutes) before each dosing occasion using a magnetic stirrer and a spatula. The test item was weighed into tared glass beaker on a suitable precision balance and the vehicle added (weight:volume). The pH of the freshly prepared dose formulations was mesaured at each occasion following preparation and was found to be between pH 6-7 for the test item. Temperature of the freshly prepared dose formulations were generally between 20-23 °C. Homogeneity of the test item in the vehicle was maintained during administration using a magnetic stirrer. The stability of the test item in the vehicle was not determined in this test. This is not considerd to be required because of the short period between dose preparation and administration to the animals.
No further information on oral exposure was stated. - Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 5 female rats
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations of mortality/viability was made daily during the acclimatization period, during the first 30 minutes and at approximately 1, 2, 3 and 5 hours after administration on the day of dosing (test day 1; with the clinical signs) and twice daily during days 2 - 15. Observations of body weight were made on the day prior to the administration of the test item, on the day of administration of the test item (prior to administration of the test item), and on days 8 and 15. Observations on clinical signs were made daily during the acclimatization period, during the first 30 minutes and at approximately 1, 2, 3 and 5 hours after the administration on test day 1. Once daily during days 2-15.
- Necropsy of survivors performed: Yes
All animals were killed by carbon dioxide asphyxiation and discarded after macroscopic examinations have been performed.
- Other examinations performed: For clinical signs all abnormalities were recorded.
No further information on the study design was stated. - Statistics:
- No statistical analysis was performed.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occured during the study.
- Clinical signs:
- other: Slightly ruffled fur was noted at the 30-minutes reading up to day 2, 4, 5 or 7 in four animals. Hunched posture was observed at the 30-minutes reading up to the 1-, 3- or 5-hour reading in these animals. Slightly to moderately ruffled fur at the 30-minut
- Gross pathology:
- No macroscopic findings were observed at necropsy.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The median lethal dose for the test item Precal 50S (Calcium dihydroxide (hydrated lime)) after single oral administration to female rats, observed over a period of 14 days is: LD50 (rat): greater than 2000 mg/kg body weight.
According to the EC Regulation No. 1272/2008 and subsequent regulations, the test item is not classified. - Executive summary:
In an acute oral toxicity study performed according to OECD TG 425, groups of 5 fasted female Wistar rats were given a single oral dose of Calcium hydroxide (98.2%) in polyethylene glycol at a dose of 2000 mg/kg bw and were observed for 14 days.
No cases of mortality were observed. There were no treatment related necropsy findings. A slight decrease in body weight between the day of dosing and day 8 was observed in one animal treated with the test item. This was an isolated and transient change and the animal recovered until the end of the observation period.
Clinical signs included slightly ruffled fur noted at the 30-minutes reading up to day 2, 4, 5 or 7 in four animals. Hunched posture was observed at the 30-minutes reading up to the 1-, 3- or 5-hour reading in these animals. Slightly to moderately ruffled fur at the 30-minutes reading up to day 13, hunched posture at the 30-minutes reading up to day 7, slight sedation at the 1-hour observation up to day 6 as well as deep respiration up to day 11 and rales at the 30-minutes observation up to day 2 were noted in the fifth animal. Clinical signs were shown to be reversible until scheduled sacrifice on day 15.
Based on these results, the LD50 for the test item after single oral administration to female rats, is greater than 2000 mg/kg body weight.
According to EC Regulation No. 1272/2008 and subsequent regulations, the test item is not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.